Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma 2024-03-29 17:20
Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights 2024-03-29 10:42
Jacobio Pharma Announces 2023 Annual Results 2024-03-29 08:50
Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade 2024-03-29 06:00
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future 2024-03-28 22:46
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
Tigermed Reports Full Year 2023 Results 2024-03-28 18:31
Sirnaomics Announces 2023 Annual Results 2024-03-28 17:09
Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients 2024-03-28 15:00
TCI Gene Enhancing Malaysia's Preventive Healthcare In Collaboration With ALPRO Pharmacy 2024-03-28 12:30
XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024 2024-03-28 09:05
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 2024-03-28 07:01
Ascentage Pharma Announces 2023 Annual Results 2024-03-27 22:30
CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates 2024-03-27 22:00
CARsgen Announced 2023 Annual Results 2024-03-27 20:50
YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean 2024-03-27 20:00
Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development 2024-03-27 20:00
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy 2024-03-27 08:00
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology 2024-03-27 06:00
WuXi Biologics Reports Solid 2023 Annual Results 2024-03-26 21:53
1 5 6 7 8 9 375